Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Linking high volume to better outcomes in TAVR

If you want something done well, ask a busy person. That was one of my dad’s adages over the years. The same is true in healthcare, as many studies have found that volume—busy-ness—and quality in medicine go hand in hand.

iRhythm’s Zio monitor shows superiority in detecting AFib over Holter devices

iRhythm Technologies, which specializes in digital cardiac care, presented encouraging results from a study on its Zio continuous ambulatory monitoring system that showed it is more efficient in detecting arrhythmias than competitors' monitors.

Medtronic RESOLUTE ONYX 2 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

Medtronic plc (NYSE: MDT) today announced that the Resolute Onyx(TM) Drug-Eluting Stent (DES) met its primary endpoint of Target Lesion Failure (TLF) at one year for the treatment of coronary artery disease in extra-small vessels. Results from the RESOLUTE ONYX 2.0 mm Clinical Study were presented today as a Hot Line/Late-Breaking Trial Session at the 2017 EuroPCR Annual Meeting and simultaneously published in the Journal of the American College of Cardiology (JACC): Cardiovascular Intervention.

Thumbnail

Boston Scientific’s TAVI system exceeds expectations in clinical trial

Boston Scientific’s transcatheter aortic valve implantation (TAVI) technology, the LOTUS Valve System, shows superiority to a similar platform made by a competitor in a new clinical trial.

Thumbnail

Early menopause could increase heart failure risk in women

New research shows that postmenopausal women who reached menopause at an earlier age or who never gave birth at all are at a higher risk for developing heart failure.

High-functioning TAVR hospitals experience fewer readmissions

Increasing productivity among cardiologists performing transcatheter aortic valve replacements (TAVR) could help lower readmissions, according to a new study that found a correlation between high-volume TAVR hospitals and lower 30-day readmission rates.

SCAI 2017: TAVR outcomes depend on individual risk factors, not valve type

A late-breaking study, presented May 12 at the Society of Cardiovascular Angiography and Interventions meeting in New Orleans, showed that factors related to individual patients—and not the specific type of valve used—determined 30-day outcomes for transcatheter aortic valve replacement (TAVR).

First Pennsylvania Patient Treated in Landmark Heart Artery Stent Trial

PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania in a trial assessing the safety and effectiveness of a new stent to treat patients with coronary heart disease who are at higher risk for bleeding.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.